A new way of interpreting standard blood tests could help doctors spot cancer warning signs sooner, according to scientists.

A new way of interpreting standard blood tests could help doctors spot cancer warning signs sooner, according to scientists.

Ade-line du Preez, a very loving five-year-old, has a dream in her heart of attending grade R this year. Unfortunately, she was diagnosed ...

Erba Transasia Group, India's No. 1 In-vitro Diagnostic (IVD) Company and among the leading global IVD players focused on ...

Here are 5 things individuals should know about the powerful impact of blood donation and the benefits becoming a donor can ...

Explore advances in von Willebrand disease treatment, including Star Therapeutics' VGA039, and other key players in the space ...

The American Red Cross urges donors to make an appointment to give lifesaving blood or platelets in the new year to help keep the blood supply strong this winter. Type O negative ...

PharmaEssentia is looking to expand the reach of its FDA-approved rare blood cancer treatment Besremi to another rare blood ...

This pattern was mostly reflected in genetic material contained in their platelets -- the small cells that form clots in ...

Blood disorders affect millions of people worldwide, yet their potential to develop into blood cancers often goes ...

CBT-004 is under clinical development by Cloudbreak Therapeutics and currently in Phase II for Unspecified Ophthalmological Disorders.

ORTHO-R is under clinical development by ChitogenX and currently in Phase II for Unspecified Musculoskeletal Disorders.